Job/Unit: O20402
/KAP1
Date: 04-09-12 15:49:07
Pages: 12
M. Hapke et al.
2.61–2.53 (m, 1 H), 2.56 (s, 3 H, -CH3), 2.44–2.24 (m, 2 H), 2.18– 13C NMR (100 MHz, CDCl3): δ = 156.0, 154.6, 154.5, 144.7, 139.9,
FULL PAPER
2.07 (m, 1 H), 1.94–1.71 (m, 3 H), 1.37–1.25 (m, 1 H) ppm. 13C
NMR (100 MHz, 318 K, CDCl3): δ = 155.5, 155.3, 153.8, 144.3,
133.3, 129.9, 129.6, 128.0, 127.9, 126.8, 124.9, 123.8, 123.6, 120.2,
114.1, 61.0, 57.0 (-OCH3), 55.3, 54.7, 32.1, 30.9, 24.3 (-CH3),
21.6 ppm. MS (ESI+): m/z (%) = 345 (100) [M + H]+. HRMS (ESI):
calcd. for C23H25N2O [M + H]+ 345.1961; found 345.1967.
C23H24N2O (344.45): calcd. C 80.20, H 7.02, N 8.13; found C
80.57, H 7.18, N 8.27.
133.4, 130.1, 130.0, 129.3, 128.6, 128.5, 128.1, 127.2, 126.7, 124.8,
123.6, 123.1, 117.5, 113.8, 60.9, 56.6, 55.7, 54.8, 32.4, 30.9,
21.6 ppm. MS (EI, GC–MS): m/z (%) = 406 (100) [M]+, 405 (77),
363 (15), 336 (20), 322 (86), 306 (33). HRMS (ESI): calcd. for
C28H27N2O [M + H]+ 407.2118; found 407.2116.
(S)-(aS)/(aR)-3-(2-Fluorophenyl)-1-(2-methylnaphthalen-1-yl)-
5,7,8,9,9a,10-hexahydro-pyrrolo[1,2-b][2,6]naphthyridine [(S)-(aS)-
18/(S)-(aR)-18]: The reaction of the chiral diyne (S)-12 with 2-fluo-
robenzonitrile was performed according to General Procedure 2.
Compound (S)-12 (600 mg, 1.98 mmol) and 2-fluorobenzonitrile
(1.07 mL, 10.89 mmol, 5.5 equiv.), together with THF (15 mL),
were cooled to 0 °C in a Schlenk flask and a solution of 15
(0.099 mmol in 0.6 mL Et2O, concentration of the catalyst stock
solution: 0.165 mmolmL–1) was added. The reaction mixture was
warmed to room temp. and stirring was continued for an additional
15 h. TLC control showed complete conversion. The dark reaction
mixture was then evaporated to dryness and chromatographic sepa-
ration (THF/n-hexane, 3:1 v/v) gave both diastereomeric atropiso-
mers (separated by chromatography column). Diastereomer 1 was
obtained in 26% (215 mg) yield and diastereomer 2 was obtained
in 18% (148 mg) yield, providing a total yield of 44% (363 mg).
Later crystals of diastereomer 2 were obtained from evaporation of
a solution in CDCl3 and the absolute configuration of the biaryl
axis was determined to be (aR). Therefore, diastereomer 1 was de-
fined as (S)-(aS)-18 and diastereomer 2 was (S)-(aR)-18.
(S)-(aR)-1-(2-Methoxynaphthalen-1-yl)-3-methyl-5,7,8,9,9a,10-hexa-
hydropyrrolo[1,2-b][2,6]naphthyridine [(S)-(aR)-16 (dia2)]: M.p.
118–121 °C. [α]2D2
=
+150.4 (c = 0.195, CHCl3). 1H NMR
(300 MHz, 295 K, CDCl3): δ = 7.89 (d, J = 9.0 Hz, 1 H), 7.82–7.77
(m, 1 H), 7.33 (d, J = 9.0 Hz, 1 H), 7.33–7.27 (m, 2 H), 7.18–7.14
(m, 1 H), 6.92 (s, 1 H), 4.19 (d, J = –15.7 Hz, 1 H), 3.79 (s, 3 H,
-OCH3), 3.44 (d, J = –15.7 Hz, 1 H), 3.29 (ddd, J = 8.6, 8.5, 2.1 Hz,
1 H), 2.56 (s, 3 H, -CH3), 2.39–2.31 (m, 2 H), 2.24–2.13 (m, 2 H),
1.90–1.78 (m, 2 H), 1.77–1.68 (m, 1 H), 1.44–1.31 (m, 1 H) ppm.
13C NMR (75 MHz, 295 K, CDCl3): δ = 155.3, 155.0, 154.3, 144.5,
133.2, 129.8, 129.2, 128.2, 128.0, 126.7, 124.6, 123.5, 122.9, 120.0,
113.6, 60.9, 56.5 (-OCH3), 55.6, 54.8, 32.3, 30.8, 24.4 (-CH3),
21.5 ppm. MS (ESI+): m/z (%) = 345 (100) [M + H]+. HRMS
(ESI+): calcd. for C23H25N2O [M + H]+ 345.1961; found 348.1966.
C23H24N2O (344.45): calcd. C 80.20, H 7.02, N 8.13; found C
80.45, H 7.07, N 7.89.
(S)-(aS)/(aR)-3-Phenyl-1-(2-methylnaphthalen-1-yl)-5,7,8,9,9a,10-
hexahydro-pyrrolo[1,2-b][2,6]naphthyridine [(S)-(aS)-17/(S)-(aR)-
17]: The reaction of the chiral diyne (S)-12 with benzonitrile was
performed according to General Procedure 2. Compound (S)-12
(400 mg, 1.32 mmol) and benzonitrile (0.68 mL, 6.6 mmol,
5 equiv.), together with THF (10 mL), were cooled to 0 °C in a
Schlenk flask, then a solution of 15 (0.066 mmol in 0.4 mL Et2O,
concentration of the catalyst stock solution: 0.122 mmolmL–1) was
added. The reaction mixture was warmed to room temp. and stir-
ring was continued for an additional 15 h. TLC control showed
complete conversion. The dark reaction mixture was then evapo-
rated to dryness and chromatographic separation (THF/n-hexane,
3:1 v/v) gave both diastereomeric atropisomers (description in the
succession of their elution from the chromatography column). Dia-
stereomer 1 was obtained in 42% (223 mg) yield and diastereomer
2 was obtained in 24% (131 mg) yield, providing a total yield of
66% (354 mg).
(S)-(aS)-3-(2-Fluorophenyl)-1-(2-methylnaphthalen-1-yl)-5,7,8,9,
9a,10-hexahydropyrrolo[1,2-b][2,6]naphthyridine [(S)-(aS)-18]: M.p.
111–112 °C. [α]2D2 = –20.9 (c = 0.546, CHCl3). 1H NMR (300 MHz,
CDCl3): δ = 7.97–7.91 (m, 1 H), 7.93 (d, J = 9.0 Hz, 1 H), 7.84–
7.81 (m, 1 H), 7.60 (d, J = 2.1 Hz, 1 H), 7.38 (d, J = 9.0 Hz, 1 H),
7.34–7.27 (m, 3 H), 7.20–7.09 (m, 3 H), 4.30 (d, J = –15.6 Hz, 1
H), 3.87 (s, 3 H, -OCH3), 3.65 (d, J = –15.6 Hz, 1 H), 3.30 (t, J =
8.5 Hz, 1 H), 2.69 (dd, J = –16.4, 3.8 Hz, 1 H), 2.54–2.30 (m, 2 H),
2.21 (dd, J = –16.4, 10.4 Hz, 1 H), 2.02–1.74 (m, 3 H), 1.42–1.29
(m, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 156.2, 153.7,
150.6, 144.2, 133.2, 131.7, 130.1 (d, J = 3.2 Hz), 130.0, 129.9, 129.4,
128.0, 126.9, 124.8, 124.5 (d, J = 3.7 Hz), 123.8, 123.2, 121.6 (d, J
= 8.5 Hz), 116.2, 115.9, 113.8, 60.8, 56.9, 55.5, 54.7, 32.3, 30.9,
21.6 ppm (not all carbon resonances detected). 19F NMR
(282 MHz, CDCl3): δ = –116.7 ppm. MS (EI, GC–MS): m/z (%) =
424 (100) [M]+, 423 (89), 381 (22), 354 (23), 340 (83), 324 (33).
HRMS (ESI): calcd. for C28H26FN2O [M + H]+ 425.2024; found
425.2029.
Diastereomer 1: M.p. 135–137 °C. [α]2D3 = –26.2 (c = 1.324, CHCl3).
1H NMR (300 MHz, CDCl3): δ = 8.02–7.97 (m, 2 H), 7.94 (d, J =
9.0 Hz, 1 H), 7.84 (dd, J = 7.0, 2.0 Hz, 1 H), 7.53 (s, 1 H), 7.45–
7.29 (m, 6 H), 7.20 (d, J = 7.7 Hz, 1 H), 4.31 (d, J = –15.6 Hz, 1
H), 3.88 (s, 3 H, -OCH3), 3.60 (d, J = –15.6 Hz, 1 H), 3.37–3.28
(m, 1 H), 2.68 (dd, J = –16.4 Hz, 1 H, 3.6 Hz), 2.45–2.13 (m, 3 H),
2.01–1.74 (m, 3 H), 1.42–1.27 (m, 1 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 156.1, 154.8, 153.7, 144.8, 139.9, 133.2, 129.9, 129.8,
129.4, 128.6, 128.5, 127.9, 127.2, 126.8, 124.9, 123.8, 123.6, 117.7,
114.0, 60.8, 57.0, 55.8, 54.7, 32.5, 30.9, 21.5 ppm. MS (EI, GC–
MS): m/z (%) = 406 (100) [M]+, 405 (81), 363 (17), 336 (23), 322
(87), 306 (32). HRMS (ESI): calcd. for C28H27N2O [M + H]+
407.2118; found 407.2123.
(S)-(aR)-3-(2-Fluorophenyl)-1-(2-methylnaphthalen-1-yl)-5,7,8,9,
9a,10-hexahydro-pyrrolo[1,2-b][2,6]naphthyridine [(S)-(aR)-18]: M.p.
117–118 °C. [α]2D4
=
+161.0 (c = 0.436, CHCl3). 1H NMR
(300 MHz, CDCl3): δ = 7.95 (dd, J = 8.0, 2.1 Hz, 1 H), 7.93 (d, J
= 9.1 Hz, 1 H), 7.86–7.81 (m, 1 H), 7.58 (d, J = 1.8 Hz, 1 H), 7.37
(d, J = 9.1 Hz, 1 H), 7.37–7.27 (m, 4 H), 7.18–7.09 (m, 2 H), 4.33
(d, J = –15.7 Hz, 1 H), 3.83 (s, 3 H, -OCH3), 3.59 (d, J = –15.7 Hz,
1 H), 3.33 (t, J = 7.6 Hz, 1 H), 2.59–2.19 (m, 4 H), 1.98–1.74 (m,
3 H), 1.53–1.37 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
156.0, 154.4, 150.3, 133.2, 131.9, 131.6 (d, J = 3.0 Hz), 130.4, 130.0,
129.8 (d, J = 8.7 Hz), 129.2, 128.0, 126.7, 124.6, 124.4 (d, J =
3.2 Hz), 123.6, 122.7, 121.4, 121.3 (d, J = 8.5 Hz), 116.1, 115.8,
113.6, 60.7, 56.5, 55.5, 54.7, 32.2, 30.7, 21.5 ppm. 19F NMR
(282 MHz, CDCl3): δ = –116.9 ppm. MS (EI, GC–MS): m/z (%) =
424 (100) [M]+, 423 (85), 381 (20), 354 (23), 340 (80), 324 (33).
HRMS (ESI): calcd. for C28H26FN2O [M + H]+ 425.2024; found
425.2029.
Diastereomer 2: M.p. 99–102 °C. [α]2D3 = +162.8 (c = 0.458, CHCl3).
1H NMR (400 MHz, CDCl3): δ = 7.94–7.90 (m, 2 H), 7.87 (d, J =
9.0 Hz, 1 H), 7.80–7.76 (m, 1 H), 7.43 (s, 1 H), 7.36–7.24 (m, 6 H),
7.31 (d, J = 9.0 Hz, 1 H), 4.26 (d, J = –15.6 Hz, 1 H), 3.76 (s, 3
H, -OCH3), 3.51 (d, J = –15.6 Hz, 1 H), 3.30–3.24 (m, 1 H), 2.44
(dd, J = –16.5, 10.8 Hz, 1 H), 2.34 (dd, J = –16.5, 3.6 Hz, 1 H),
2.26–2.14 (m, 2 H), 1.89–1.66 (m, 3 H), 1.43–1.32 (m, 1 H) ppm.
(S)-(aS)-3-Methyl-1-(2-methylnaphthalen-1-yl)-5,7,8,9,9a,10-hexa-
hydropyrrolo[1,2-b][2,6]naphthyridine [(S)-(aS)-19]: Compound (S)-
8
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0